Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1990-2-14
|
pubmed:abstractText |
Expression vectors have been constructed for a region of the human retinoic acid receptor-alpha (hRAR-alpha) and transferred into F9 embryonal carcinoma (EC) cells. When the vectors are overexpressed in F9 cells, clones can be selected for resistance to retinoic acid-induced differentiation. This effect is obtained even when the hRAR-alpha region is expressed as a beta-galactosidase fusion protein. Using the beta-galactosidase component of the fusion protein as a marker, overexpression of the fusion protein has been correlated with the retinoic acid-resistance effect. The clones resistant to retinoic acid no longer exhibit the normal retinoic acid induction of endo B cytokeratin, laminin B-1, and tissue plasminogen activator mRNAs observed with normal F9 cells. Retinoic acid induction of type IV alpha-1 collagen and Hox-1.3 RNAs is observed with these clones. When transfected with a thyroid receptor DNA-binding sequence (TRE)/thymidine kinase promoter/luciferase construct, the retinoic acid-resistant clones do not yield the same retinoic acid-induced level of luciferase obtained with F9 cells. It is hypothesized that the RAR vectors are interfering with endogenous RAR(s) in a dominant-negative manner to inhibit retinoic acid-induced differentiation of F9 EC cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0890-9369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1647-56
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2558044-Blotting, Northern,
pubmed-meshheading:2558044-Blotting, Western,
pubmed-meshheading:2558044-Carrier Proteins,
pubmed-meshheading:2558044-Cell Differentiation,
pubmed-meshheading:2558044-Cell Line,
pubmed-meshheading:2558044-Cloning, Molecular,
pubmed-meshheading:2558044-Embryonal Carcinoma Stem Cells,
pubmed-meshheading:2558044-Gene Expression,
pubmed-meshheading:2558044-Genetic Vectors,
pubmed-meshheading:2558044-Humans,
pubmed-meshheading:2558044-Neoplastic Stem Cells,
pubmed-meshheading:2558044-Phenotype,
pubmed-meshheading:2558044-Receptors, Retinoic Acid,
pubmed-meshheading:2558044-Recombinant Fusion Proteins,
pubmed-meshheading:2558044-Transfection,
pubmed-meshheading:2558044-Tretinoin
|
pubmed:year |
1989
|
pubmed:articleTitle |
Retinoic acid receptor expression vector inhibits differentiation of F9 embryonal carcinoma cells.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Duke University Medical Center, North Carolina 27710.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|